An underground market for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.
Experimental Treatment Gaining Popularity Via Social Media
The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Followers are encouraged to message these accounts privately for supplier links, while also obtaining discount codes.
Active Commerce on Messaging Platforms
Separately, a robust market exists on Telegram, where communities with thousands of members share “before and after” images, administration instructions and claims of next-day British shipping. Sellers promote the drug there before directing customers to other platforms for transactions.
Understanding The Experimental Drug
This medication is an experimental injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Healthcare Professionals Voice Worries
However, doctors and chemists have cautions that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to individuals administering substances of uncertain source.
Several experts said the popularity for retatrutide could be connected to the rising cost of approved weight loss products such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.
Several influencers try to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still breach medicines, advertising, and customer laws, potentially leading to penalties, prosecution or imprisonment.
Service Reaction and Material Removal
According to TikTok, the service has removed problematic material and banned related keywords and query recommendations. The organization said it was committed to maintaining the platform secure and investing in enhancing enforcement strategies.
Digital Marketplace Operations
Research also discovered communities with up to 9,000 members marketing the experimental drug using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly brings up channels with thousands of users, populated with photos of slimming results, glowing testimonials and detailed instructions for mixing or administering at home.
After moments of entering one group, a seller shared WhatsApp details, where most transactions occur. The vendor sent an guidebook and promised shipping within two days. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one inquired about body mass, medical conditions or previous experience.
Product Details and Costs
Within these communities, messages show black plastic packages with postal service stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors typically sold at £160 for 20mg. When questioned how much time a pen should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for the messaging service said it regularly monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are administering materials they cannot confirm. Although the research behind this drug is valid, these digital versions may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the increase in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With costs increasing, individuals are using social media. But fake injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.
Her team has already encountered individuals harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated Wyllie. “These materials could be contaminated or improperly measured.”
Producer Statement
A representative from Eli Lilly said the substance was in phase 3 research studies and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly investigational substance not yet approved … may subject users to potentially significant health risks”.
